Terms: = Lymphoma AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130 AND Treatment
9 results:
1. [Clinical and molecular biological characterization of patients with accelerated chronic lymphocytic leukemia].
Zhou ZY; Dai LMJ; Sha YQ; Qiu TL; Qin SC; Miao Y; Xia Y; Wu W; Tang HN; Xu W; Li JY; Zhu HY
Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):917-923. PubMed ID: 38185521
[No Abstract] [Full Text] [Related]
2. Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.
Sakakibara S; Tosato G
J Interferon Cytokine Res; 2011 Nov; 31(11):791-801. PubMed ID: 21767154
[TBL] [Abstract] [Full Text] [Related]
3. New markers for minimal residual disease detection in acute lymphoblastic leukemia.
Coustan-Smith E; Song G; Clark C; Key L; Liu P; Mehrpooya M; Stow P; Su X; Shurtleff S; Pui CH; Downing JR; Campana D
Blood; 2011 Jun; 117(23):6267-76. PubMed ID: 21487112
[TBL] [Abstract] [Full Text] [Related]
4. IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing.
Regis G; Icardi L; Conti L; Chiarle R; Piva R; Giovarelli M; Poli V; Novelli F
Leukemia; 2009 Nov; 23(11):2102-8. PubMed ID: 19626047
[TBL] [Abstract] [Full Text] [Related]
5. Cytostatic and cytocidal effects of mistletoe (Viscum album L.) quercus extract Iscador.
Kovacs E; Link S; Toffol-Schmidt U
Arzneimittelforschung; 2006 Jun; 56(6A):467-73. PubMed ID: 16927528
[TBL] [Abstract] [Full Text] [Related]
6. Comparative activity of Sant7 and anti-IL-6, IL-6R monoclonal antibodies in a murine model of B-cell lymphoma.
Campo S; Serlupi-Crescenzi O; Arseni B; Rossi S; Saggio I; Salone B; Cherubini G; Carminati P; De Santis R
Cytokine; 2005 Sep; 31(5):368-74. PubMed ID: 16061391
[TBL] [Abstract] [Full Text] [Related]
7. Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does viscum album treatment affect these parameters?
Kovacs E; Kuehn JJ
Biomed Pharmacother; 2002 May; 56(3):152-8. PubMed ID: 12046687
[TBL] [Abstract] [Full Text] [Related]
8. Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines.
Drexler HG; Meyer C; Gaidano G; Carbone A
Leukemia; 1999 Apr; 13(4):634-40. PubMed ID: 10214873
[TBL] [Abstract] [Full Text] [Related]
9. Blocking interleukin-6 activity with chimeric anti-IL6 monoclonal antibodies in multiple myeloma: effects on soluble IL6 receptor and soluble gp130.
Van Zaanen HC; Lokhorst HM; Aarden LA; Rensink HJ; Warnaar SO; Van Oers MH
Leuk Lymphoma; 1998 Nov; 31(5-6):551-8. PubMed ID: 9922045
[TBL] [Abstract] [Full Text] [Related]